Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene...
5 insider sale filings on record · latest filing 2026-10-01.
No open-market insider purchases (SEC Form 4 code P) on record for LEGN.